Viral Hepatitis

Viral hepatitis is a global public health problem affecting millions of people every year, all around the world causing disability and death. Reasonable measures, such as vaccination, safe injections, safe food, and safe blood supply can decrease the rate of transmission of viral hepatitis. Many of these measures not only reduce the transmission of viral hepatitis but also have spill over effects on the prevention of various other contagious diseases. Furthermore, current therapies for hepatitis B and C give health care providers effective tools to combat the disease. New advanced therapies are also being developed for hepatitis B and C, and the future is more promising than ever. Antiretrovirals such as  TDF, 3TC, & FTC are effective for treatment of both HIV and HBV infections. The co-infected patients can take fewer drugs to treat these two diseases. Viral hepatitis can also be prevented by taking vaccines on time and maintaining proper hygiene.

  • Screening test
  • Antiretroviral drugs
  • Safe injection practices
  • Blood safety strategies
  • Evaluation and Management of chronically-infected persons
  • Personal & Community Hygiene
  • Antiviral Drugs like lamivudine,& Adefovir
  • Pegylated interferon Injections

Related Conference of Viral Hepatitis

January 21-22, 2021

7th Rare Diseases and Orphan Drugs

Vienna, Austria
February 15-16, 2021

8th International Congress on Infectious Diseases

London, UK
May 10-11, 2021

4th Global Experts Meeting on Infectious Diseases

Singapore City, Singapore
August 16-17, 2021

13th Global Infections Conference

Tokyo, Japan
September 06-07, 2021

11th World Congress on Rare Diseases and Orphan Drugs

Berlin, Germany

Viral Hepatitis Conference Speakers

Recommended Sessions

Related Journals

Are you interested in